Lithium Ion

Lithium Ion

SCHEMBL4750393

NC1Cc2ccccc2OC1(Cc1ccccc1)Cc1ccccc1.[Al+3].[H-].[H-].[H-].[H-].[Li+]

nearest known ligand 0.39

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

GSK3AGSK3BIMPA1

The experimentally established mechanism targets of Lithium Ion. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 5/20 0.39
DRD2 P14416 1/20 0.37
HTR2A P28223 1/20 0.37
MAOA P21397 9/20 0.35
MAOB P27338 9/20 0.35
LMNA P02545 1/20 0.35
HTT P42858 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
HTR1A P08908 2/20 0.34
ADRA2A P08913 1/20 0.34
ADRA2B P18089 1/20 0.34
ADRA2C P18825 1/20 0.34
KDM1A O60341 4/20 0.33
AOC2 O75106 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5914697 0.69 MAOB (0.38) HTR2AMAOAMAOBKDM1AAOC2
SCHEMBL10192535 0.67 MAOA (0.37) MAOAMAOBLMNAHTTAOC2
SCHEMBL28122562 0.67 MAOB (0.44) MAOAMAOBKDM1A
SCHEMBL27853297 0.63 MAOA (0.39) SIGMAR1MAOAMAOBL3MBTL1KDM1A
SCHEMBL19289110 0.61 TSHR (0.38) SIGMAR1LMNANPSR1L3MBTL1ADRA2A
Cadaverine Tartrate SCHEMBL14359634 0.60 MAOB (0.33) MAOAMAOBAOC2
SCHEMBL7846851 0.60 HRH3 (0.38) MAOAMAOBLMNANPSR1ADRA2A
SCHEMBL30528365 0.60 DRD2 (0.53) SIGMAR1DRD2HTR2AMAOAMAOB
SCHEMBL10366357 0.59 HTR1A (0.50) SIGMAR1MAOAMAOBHTR1AADRA2A
SCHEMBL16499182 0.58 MAOB (0.34) MAOAMAOBAOC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008130319-A2 NOVEL N-TETRAHYDRONAPHTALENE OR N-CHROMANE CARBOXAMIDE DERIVATIVES FOR THE TREATMENT OF PAIN ASTRAZENECA AB (SE) 2008-10-30 WO disclosed